ByJohn A
Pharmacy, Prescriber, and Fulfillment Standards for Best GLP-1 Providers by State
Three separate approvals stand behind any mailed GLP-1 prescription: the prescriber’s license in the state where the patient sits, the dispensing pharmacy’s authority to ship into that state, and, for compounded product, the compounder’s standing as a state-licensed pharmacy or an FDA-registered outsourcing facility. Different regulators hold each record, and all three are checkable by name.
Three entities, three regulators
Patients tend to think of a telehealth weight service as one company. Operationally it is a stack. A technology platform runs intake and billing. A medical group or a network of independent clinicians writes prescriptions. A pharmacy dispenses and ships. Sometimes a fourth party, an outsourcing facility, manufactures the compounded preparation that the pharmacy sends out. Marketing usually presents the stack as a single brand, but oversight lands on the individual entities.
The prescriber is regulated by the medical board of the state where the patient is located during the encounter. The pharmacy is regulated by that same state’s board of pharmacy, which typically issues a nonresident or out-of-state license to any pharmacy shipping in from elsewhere. Outsourcing facilities register with FDA and appear on a published federal list. State-licensed compounding pharmacies do not appear on that federal list, because their oversight sits with the state board.
Who holds which record
| Entity | Primary regulator | What to ask the service for | Where to confirm it |
|---|---|---|---|
| Prescribing clinician | State medical board where the patient is located | Full name and credential of the clinician who signs the prescription | State medical board license verification |
| Dispensing pharmacy | State board of pharmacy in the patient’s state | Pharmacy name and the state it dispenses from | Board of pharmacy licensee search, including nonresident licensees |
| 503A compounding pharmacy | State board of pharmacy | Whether the preparation is compounded and by whom | State board record for that pharmacy |
| 503B outsourcing facility | FDA registration, plus state licensure | Facility name if compounding is done at scale | FDA’s Registered Outsourcing Facilities list |
| Shipping and cold chain | Pharmacy practice standards | Carrier, transit time, and packaging method | The written shipping terms before payment |
Why 503A and 503B change what you can look up
Federal compounding law splits compounders into two categories. A 503A pharmacy compounds for an identified patient against a prescription and is licensed by its state board. A 503B outsourcing facility may compound larger batches without patient-specific prescriptions, registers with FDA, and is subject to federal inspection and current good manufacturing practice requirements. Neither route produces an FDA-approved drug. Approval attaches to a specific product that has been through a marketing application, and no compounded preparation has one.
That distinction matters for verification more than for quality claims. If a service says its medication comes from a 503B facility, that claim is checkable against a federal list in under a minute. If it comes from a 503A pharmacy, the record you want is at the state board. A service that will not say which applies has removed your ability to check either.
Comparing what services will confirm in writing
Most disputes about quality come down to what a company is willing to put on paper before money changes hands. Useful requests are specific: the name of the dispensing pharmacy, whether the preparation is compounded, the beyond-use date policy, and whether shipments travel with temperature control. Services differ widely in how much of that they answer up front, and the difference is informative.
Availability and sourcing tables published by the platforms are a reasonable starting point. A state-level comparison from FormBlends sits alongside similar pages from Ro, Hims and Hers, Henry Meds, and Mochi Health, and the test for any of them is whether the licensure detail on the page matches what the provider behind it will confirm in writing when asked directly. Manufacturer channels sidestep the question by construction: LillyDirect ships Zepbound and NovoCare ships Wegovy, both FDA-approved products with approved labeling.
Fulfillment details that are easy to check and easy to skip
GLP-1 preparations are temperature sensitive, and the handling instructions on approved product labeling are specific about refrigeration and about how long a product may sit at room temperature. Compounded preparations carry their own beyond-use dating set by the compounder. A shipment that arrives warm after sitting in a delivery vehicle is a real problem, and the practical question to ask before ordering is what the service does when that happens. A stated replacement policy is worth more than a promise of insulated packaging.
Labeling is the other overlooked item. A dispensed prescription should arrive with the pharmacy’s name, the patient’s name, the drug and strength, the prescriber, and a date. Vials that arrive without dispensing labels are a departure from ordinary pharmacy practice regardless of what the website says. Case reports published in the poison control literature describe dosing errors involving compounded semaglutide, several of them traceable to confusing units and unfamiliar labeling rather than to the molecule.
None of these checks depend on which brand name is printed on the box. A patient comparing services such as Ro, Henry Meds, Hims and Hers, and HealthRX for GLP-1 medications can run the same three-license test against each one, and the manufacturer channels, LillyDirect and NovoCare, shorten the list to prescriber and pharmacy alone because the product is already approved. The service that answers all three questions in writing is the one that has made itself checkable.
Frequently asked questions
Does an FDA-registered facility mean the medication is FDA-approved?
No. Registration means the facility has told FDA it operates as an outsourcing facility and accepts federal inspection. Approval is a separate process applied to a specific product after review of safety, effectiveness, and manufacturing. Compounded preparations do not go through it, whoever makes them.
Can a pharmacy in another state legally ship to me?
Generally yes, if it holds a nonresident pharmacy license issued by the board of pharmacy in your state. That is a routine credential rather than an exception. The board’s licensee search will show whether a named pharmacy holds one and whether the license is currently in good standing.
What if the service will not name its pharmacy?
Some decline before an order is placed for commercial reasons. The name will appear on the dispensing label when the package arrives, so the check is still possible after the fact. Whether waiting until then is acceptable is a judgment call, and other services will answer the question immediately.
Do I need to verify anything if I use a brand product?
Less of it. An FDA-approved product from a manufacturer channel removes the compounding questions entirely, though the prescriber licensure and pharmacy licensure questions still apply to whoever writes and fills the prescription. The verification list simply gets shorter rather than disappearing.
Is compounding legal at all if shortages have ended?
Compounding remains legal, and pharmacies compound many products routinely. What federal law limits is making what amounts to a copy of an approved drug, an allowance tied in part to shortage status. FDA publishes the current shortage list, which is the record that settles the question at any given moment.
